| |
| |
|
| Insider
Information: |
Rolph Timothy |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
182,558 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
182,558 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
182,558 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-03-13 |
4 |
S |
$28.33 |
$17,536 |
D/D |
(619) |
182,558 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-12-14 |
4 |
S |
$20.76 |
$10,671 |
D/D |
(514) |
182,672 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
32,497 |
183,186 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-09-13 |
4 |
AS |
$50.34 |
$26,731 |
D/D |
(531) |
150,689 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-06-16 |
4 |
S |
$54.58 |
$4,284,066 |
D/D |
(78,200) |
151,220 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-06-16 |
4 |
OE |
$0.61 |
$24,400 |
D/D |
40,000 |
229,420 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-06-13 |
4 |
AS |
$55.16 |
$28,076 |
D/D |
(509) |
189,420 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-03-10 |
4 |
D |
$43.47 |
$26,212 |
D/D |
(603) |
189,929 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-12-29 |
4 |
AS |
$50.55 |
$1,037,119 |
D/D |
(20,316) |
190,532 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-12-29 |
4 |
OE |
$28.35 |
$221,584 |
D/D |
7,816 |
210,848 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-12-28 |
4 |
AS |
$50.00 |
$85,006 |
D/D |
(1,700) |
203,032 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-12-28 |
4 |
OE |
$28.35 |
$48,195 |
D/D |
1,700 |
204,732 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,195 |
203,032 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-11-16 |
4 |
AS |
$45.45 |
$179,464 |
D/D |
(3,947) |
183,837 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-11-15 |
4 |
AS |
$45.04 |
$141,343 |
D/D |
(3,138) |
187,784 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-26 |
4 |
AS |
$45.03 |
$214,433 |
D/D |
(4,762) |
190,922 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-25 |
4 |
AS |
$45.09 |
$480,349 |
D/D |
(10,653) |
195,684 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-25 |
4 |
OE |
$6.36 |
$103,116 |
D/D |
10,000 |
206,337 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-06 |
4 |
AS |
$39.29 |
$884,025 |
D/D |
(22,500) |
186,337 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-06 |
4 |
OE |
$21.09 |
$210,900 |
D/D |
10,000 |
208,837 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-09-30 |
4 |
AS |
$31.38 |
$1,472,400 |
D/D |
(45,000) |
198,837 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-09-30 |
4 |
OE |
$6.36 |
$328,589 |
D/D |
20,000 |
243,837 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-09-13 |
4 |
AS |
$29.18 |
$656,550 |
D/D |
(22,500) |
223,837 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-09-13 |
4/A |
AS |
$29.18 |
$656,550 |
D/D |
(22,500) |
233,837 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-09-13 |
4/A |
OE |
$6.36 |
$63,600 |
D/D |
10,000 |
256,337 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
